Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0555 per EA under NDC 59651036201. Its NADAC has been published 275 times since Aug 11, 2021.

FDA first approved this application on May 8, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0555per EA

Strength

800 mg/1

NDC

59651036201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA213794

FDA Approved

5/8/2020

TE Code

AB

On Market Since

5/8/2020

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 275 times since Aug 11, 2021, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0555 per EA
All-time high$0.0839 (Aug 11, 2021)
All-time low$0.0511 (Nov 20, 2024)
52-week high$0.0585
52-week low$0.0549
Median price$0.0651
Average price$0.0650
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked275
Tracking sinceAug 11, 2021

Price History

1W

0.0%

1M

-3.1%

3M

-0.2%

6M

-2.4%

1Y

-4.2%

3Y

-14.7%

5Y

-31.6%

All

-33.8%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0555 per EA (NDC 59651036201), effective Nov 11, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 33.8%. It has been tracked across 275 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Aug 11, 2021, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0839 (Aug 11, 2021), with a median of $0.0651 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 59651036201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.